• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

TISSUE REGENIX GROUP PLC

Notes

No. Proposition For Against Abstain
1

TO RECEIVE THE COMPANYS ANNUAL ACCOUNTS, STRATEGIC REPORT AND DIRECTORS AND AUDITORS REPORTS FOR THE YEAR ENDED 31 DECEMBER 2024

2

TO REAPPOINT DAVID COCKE, WHO RETIRES BY ROTATION, AS A DIRECTOR OF THE COMPANY

3

TO REAPPOINT JONATHAN GLENN, WHO RETIRES BY ROTATION, AS A DIRECTOR OF THE COMPANY

4

TO REAPPOINT SHERVANTHI HOMER-VANNIASINKAM, WHO RETIRES BY ROTATION, AS A DIRECTOR OF THE COMPANY

5

TO REAPPOINT DANIEL LEE, WHO RETIRES BY ROTATION, AS A DIRECTOR OF THE COMPANY

6

TO REAPPOINT BRIAN PHILLIPS, WHO RETIRES BY ROTATION, AS A DIRECTOR OF THE COMPANY

7

TO REAPPOINT TREVOR PHILLIPS, WHO RETIRES BY ROTATION, AS A DIRECTOR OF THE COMPANY

8

TO REAPPOINT RSM UK AUDIT LLP AS AUDITORS OF THE COMPANY

9

TO AUTHORISE THE DIRECTORS TO DETERMINE THE REMUNERATION OF THE AUDITORS

10

THAT THE DIRECTORS BE AUTHORISED TO ALLOT RELEVANT SECURITIES UP TO AN AGGREGATE NOMINAL AMOUNT OF 23,798.545 GBP

11

THAT SUBJECT TO RESOLUTION 10 THE DIRECTORS BE AUTHORISED TO ALLOT EQUITY SECURITIES FOR CASH AS IF SECTION 561(1) OF THE ACT DID NOT APPLY

12

THAT THE COMPANY BE AUTHORISED TO MAKE MARKET PURCHASES OF ORDINARY SHARES OF 0.1P EACH IN THE CAPITAL OF THE COMPANY